What Comes After Wellness Trends? The Shift Towards More Evidence-Led Consumer Choices

Wellness moves quickly. One year brings adaptogenic drinks and sleep trackers; the next brings cold plunges, glucose monitors or another ingredient positioned as the missing piece of modern health. The appetite behind these cycles remains strong, but there are signs that some consumers are becoming more interested in what sits behind the claims.

McKinsey & Company’s 2025 wellness research surveyed more than 9,000 consumers across China, Germany, the UK and the US. It described a global wellness industry worth around $2 trillion (McKinsey & Company, 2025). In the US, 84% of respondents said wellness was a “top” or “important” priority, while Gen Z and millennials represented 36% of the adult population but accounted for more than 41% of annual wellness spending (McKinsey & Company, 2025).

The next phase of wellness may therefore be shaped not only by which ideas attract attention, but by how consumers judge them. Ingredients, doses, study quality, transparency and the limits of available evidence all matter when separating an interesting proposition from a well-supported one.

The Wellness Market Is Asking More Questions

Interest in new wellness products hasn’t disappeared. What may be changing is the amount of scrutiny that accompanies it.

McKinsey’s 2024 research reflected this interest in science-backed wellness by asking, “What does the science say?” (McKinsey & Company, 2024). Its 2025 research also identified a segment of highly engaged consumers who conduct extensive research, seek science-backed solutions and look to doctors for advice, while remaining more likely than other groups to be influenced by social media (McKinsey & Company, 2025).

This suggests a more complicated purchasing journey than a simple choice between science and trends. Discovery may still happen through a creator, podcast or algorithm, while some consumers also seek scientific information, product details or medical advice before buying.

That makes transparency increasingly relevant. For example, Accentrate Minerals 110 by Fenix Health Science identifies magnesium as magnesium glycinate chelate, zinc as zinc glycinate chelate and iron as ferrous bisglycinate chelate, alongside dosage information. Listing ingredients clearly doesn’t prove a health outcome, but it gives consumers specific information they can assess rather than relying on a general wellness claim.

The next question is whether the evidence supports the benefit being discussed, at an appropriate dose and in a relevant population.

What Evidence-Led Shopping Actually Means

Evidence-led consumption doesn’t require shoppers to become research scientists. It does require a better way of judging claims.

Different forms of evidence answer different questions. Laboratory research can help explain a biological mechanism. Observational studies can identify associations. Randomized controlled human trials can provide stronger evidence about cause and effect when they are properly designed and relevant to the claim being made.

The Federal Trade Commission (FTC) states that objective health claims should be supported by “competent and reliable scientific evidence” (Federal Trade Commission, 2022). For many health-benefit claims, the agency generally expects randomized, controlled human clinical testing. It also considers factors including sample size, study duration, outcome measures, methodological quality and how the findings fit within the wider body of relevant evidence (Federal Trade Commission, 2022).

One positive study is therefore not automatically conclusive.

Consumers can start with a few practical questions. What exactly was studied? Who participated? What dose or formulation was tested? How long did the study last? What outcome changed? Has the result been replicated?

These questions help reveal whether a scientific reference actually supports the claim attached to it.

An Ingredient Isn’t the Same as an Outcome

One common leap in wellness marketing is moving from “this nutrient performs a function in the body” to “this particular product will produce a specific result.”

Those are different claims.

Research on an isolated ingredient can’t automatically validate every formula containing that ingredient. Dose, chemical form, other ingredients, baseline nutritional status and the characteristics of the study population can all affect whether research applies to a finished product.

This is also why product-specific language matters. The FTC makes advertisers responsible for both express and implied claims. A business can’t suggest an effect indirectly that it couldn’t substantiate if it made the same claim directly (Federal Trade Commission, 2022).

Regulatory status shouldn’t be confused with proof of efficacy either. The FDA doesn’t determine whether dietary supplements are effective before they are marketed, and supplements don’t undergo the same pre-market approval process as medicines (National Institutes of Health, Office of Dietary Supplements, 2023).

A product being legally available for sale is therefore not, by itself, evidence that every claimed benefit has been clinically demonstrated.

The Trust Signals Worth Looking For

As consumers become more selective, useful trust signals may be less dramatic than testimonials or trending ingredients.

Clear labels matter. So do precise serving information, transparent ingredient forms, legally required warnings and a willingness to communicate uncertainty.

Quality controls also need careful interpretation. Independent laboratory testing or certification may provide information about identity, potency, purity or contaminants, depending on the scope and quality of the program. The NIH Office of Dietary Supplements notes that independent organizations offer quality testing and may allow qualifying products to display seals indicating that certain manufacturing, ingredient and contaminant standards have been met. Such seals don’t guarantee that a supplement is safe or effective (National Institutes of Health, Office of Dietary Supplements, 2023).

Testing, certification and clinical efficacy therefore answer different questions.

Study quality deserves the same caution. A small study can be well conducted, but its findings may be imprecise and less generalizable, particularly when they haven’t been replicated.

Statistical significance also has limits. A statistically significant result may represent a small or clinically unimportant effect. The FTC specifically distinguishes statistical significance from a result that is meaningful to consumers, noting that a statistically significant finding may still be too small to have practical health consequences (Federal Trade Commission, 2022).

Study duration, choice of outcome and relevance to the marketed product all affect what can reasonably be concluded.

What This Means for Wellness Businesses

For businesses, evidence-led consumer behavior changes what builds lasting credibility.

Speed and novelty can still attract attention, but trust is harder to replicate. Companies that communicate precisely, substantiate their claims and avoid presenting early-stage evidence as settled science are better positioned to retain credibility when consumers investigate further.

This doesn’t mean every product needs an enormous portfolio of clinical trials. The level and type of evidence should match the claim. A modest claim supported by appropriate evidence is more defensible than a dramatic one built on a biological theory or a study that tested something materially different.

It also makes scientific communication a business skill. Research has to be translated for non-specialist readers without removing the details that affect its meaning. Phrases such as “clinically studied” or “science-backed” are far less informative when they are detached from questions about the population, formulation, duration and outcome studied.

Conclusion

Wellness trends aren’t disappearing. New categories will continue to emerge, consumers will continue to experiment and social platforms will continue to accelerate attention.

What may be changing is the level of scrutiny applied to those ideas.

A more evidence-led wellness market doesn’t require consumers to reject innovation or demand perfect proof before making every low-risk lifestyle choice. It means asking better questions: What is actually being claimed? What evidence supports it? Was the same ingredient, dose or finished product studied? How strong is the effect? What remains uncertain?

For wellness businesses, the implication is equally clear. Scientific language alone doesn’t create credibility. Transparency, proportionate claims and evidence that genuinely matches those claims do.

Trends can create attention quickly. Trust takes longer to build, but it is likely to last longer too.

References

Federal Trade Commission. (2022, December 20). Health products compliance guidance. 

McKinsey & Company. (2024, January 16). The trends defining the $1.8 trillion global wellness market in 2024. 

McKinsey & Company. (2025, May 29). The future of wellness trends survey 2025. 

National Institutes of Health, Office of Dietary Supplements. (2023, January 4). Dietary supplements: What you need to know. 

[Photo by Beniam: https://www.pexels.com/photo/diverse-group-enjoying-outdoor-yoga-session-33650006/]

‍